Page last updated: 2024-10-15

n-carbamoyl-beta-alanine and Diabetes Mellitus, Type 2

n-carbamoyl-beta-alanine has been researched along with Diabetes Mellitus, Type 2 in 1 studies

N-carbamoyl-beta-alanine: RN given refers to parent cpd
N-carbamoyl-beta-alanine : A beta-alanine derivative that is propionic acid bearing a ureido group at position 3.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pelantová, H1
Bugáňová, M1
Holubová, M1
Šedivá, B1
Zemenová, J1
Sýkora, D1
Kaválková, P1
Haluzík, M1
Železná, B1
Maletínská, L1
Kuneš, J1
Kuzma, M1

Other Studies

1 other study available for n-carbamoyl-beta-alanine and Diabetes Mellitus, Type 2

ArticleYear
Urinary metabolomic profiling in mice with diet-induced obesity and type 2 diabetes mellitus after treatment with metformin, vildagliptin and their combination.
    Molecular and cellular endocrinology, 2016, 08-15, Volume: 431

    Topics: Adamantane; Animals; beta-Alanine; Diabetes Mellitus, Type 2; Diet; Glucose Tolerance Test; Hypoglyc

2016